Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CMC-001

Known as: CMC 001 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
ObjectTo evaluate the efficacy of three dose levels of the oral hepatobiliary manganese-based magnetic resonance imaging (MRI… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Review
2012
Review
2012
Manganese is one of the most abundant metals on earth and is found as a component of more than 100 different minerals. Besides… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2011
2011
This paper discusses the development and clinical applications of positive manganese based MR contrast agents, including both… Expand
  • table 1
  • table 2
2011
2011
AbstractObjectivesTo compare the sensitivity of MRI to detect colorectal cancer liver metastases (CRLM) after ingestion of… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2010
2010
Objectives:Recently, an oral contrast agent (CMC-001, CMC Contrast, Lund, Sweden) containing manganese chloride tetrahydrate… Expand
2006
2006
Recently, a new oral liver-specific manganese-based MR agent (CMC-001) has been introduced. This contrast medium is delivered to… Expand
  • figure 1
  • figure 4
  • figure 3
2006
2006
RATIONALE AND OBJECTIVES The purpose of the study was a preliminary evaluation of a new oral, manganese-based, liver-specific… Expand
2004
2004
RATIONALE AND OBJECTIVES Manganese is a well-known liver-specific agent used in magnetic resonance imaging. For this purpose… Expand
2004
2004
RATIONALE AND OBJECTIVES To study the magnetic resonance imaging signal intensity of the liver and gall bladder before and after… Expand
2004
2004
To evaluate the effect of a new oral manganese contrast agent (CMC-001) on magnetic resonance imaging (MRI) intensities at… Expand
  • table 1
  • table 5
  • table 2
  • table 3
  • table 4